Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 8
2006 45
2007 48
2008 49
2009 49
2010 44
2011 52
2012 38
2013 32
2014 50
2015 68
2016 46
2017 43
2018 37
2019 29
2020 41
2021 43
2022 27
2023 32
2024 31
2025 52
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

769 results

Results by year

Filters applied: . Clear all
Page 1
Aptamers as Therapeutics.
Nimjee SM, White RR, Becker RC, Sullenger BA. Nimjee SM, et al. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:61-79. doi: 10.1146/annurev-pharmtox-010716-104558. Annu Rev Pharmacol Toxicol. 2017. PMID: 28061688 Free PMC article. Review.
Aptamer-based targeted therapy.
Zhu G, Chen X. Zhu G, et al. Adv Drug Deliv Rev. 2018 Sep;134:65-78. doi: 10.1016/j.addr.2018.08.005. Epub 2018 Aug 17. Adv Drug Deliv Rev. 2018. PMID: 30125604 Free PMC article. Review.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Therapeutic Applications of Aptamers.
Santarpia G, Carnes E. Santarpia G, et al. Int J Mol Sci. 2024 Jun 19;25(12):6742. doi: 10.3390/ijms25126742. Int J Mol Sci. 2024. PMID: 38928448 Free PMC article. Review.
Emerging cancer-specific therapeutic aptamers.
Yoon S, Rossi JJ. Yoon S, et al. Curr Opin Oncol. 2017 Sep;29(5):366-374. doi: 10.1097/CCO.0000000000000389. Curr Opin Oncol. 2017. PMID: 28692589 Free PMC article. Review.
Aptamers-Diagnostic and Therapeutic Solution in SARS-CoV-2.
Wandtke T, Wędrowska E, Szczur M, Przybylski G, Libura M, Kopiński P. Wandtke T, et al. Int J Mol Sci. 2022 Jan 26;23(3):1412. doi: 10.3390/ijms23031412. Int J Mol Sci. 2022. PMID: 35163338 Free PMC article. Review.
769 results